Extraction of circulating nucleic acids from human blood from SNBTS

  • Research type

    Research Study

  • Full title

    Extraction of circulating nucleic acids from human blood from Scottish National Blood Transfusion Service (SNBTS) via microfluidic processing

  • IRAS ID

    249649

  • Contact name

    Maiwenn Kersaudy-Kerhoas

  • Contact email

    m.kersaudy-kerhoas@hw.ac.uk

  • Sponsor organisation

    Heriot-Watt University

  • Clinicaltrials.gov Identifier

    EPSRC funding, EP/R0039; Rose trees Trust funding, A1579/M717

  • Duration of Study in the UK

    4 years, 0 months, 1 days

  • Research summary

    Circulating nucleic acids (cNA) are biomarkers ubiquitously present in human blood. Their potential application for screening, prognosis and monitoring of various diseases, such as cancer, has been a focus of research. Extraction of cNA from human plasma could provide material for fast and robust diagnostic data, without the need for invasive tissue sampling. However the bottleneck restricting their clinical implementation is the pre-analytical step. The aim of this project is to develop novel sustainable clinically-relevant micro and meso-scale fluidic technologies for medical blood sample preparation, preserving cNA integrity and reducing the time to result for critical tests. We will develop microfluidic chips, which are devices operating with very small volumes (from pL to uL), capable of extracting nucleic acids from blood plasma in an automated manner. We will use blood samples from the Scottish National Blood Transfusion Service (SNBTS), which are taken as a part of routine blood donations and would be otherwise discarded. Then we will compare our chips to the existing laborious technologies by extracting, quantifying and characterising circulating nucleic acids from the anonymous SNBTS blood samples. Our tool has a potential to be deployed in various medical settings, including field hospitals, at the patient bedside and in developing countries providing rapid diagnostic device for various diseases and conditions.

  • REC name

    HSC REC A

  • REC reference

    18/NI/0148

  • Date of REC Opinion

    14 Aug 2018

  • REC opinion

    Favourable Opinion